结合的最后一条规则:我们从非最佳的同时心脏结局和问题的潜在解决方案中学到的东西
Venkatesh K Ariyamuthu1, Xingxing S Cheng2, Benjamin Hippen3
1Division of Nephrology, University of Arizona, Tucson, AZ.
Transplantation
|March 12, 2025
概括
2018年成人心脏分配政策修订增加了同时心脏移植 (SHKT),但也提高了死亡率和移植失败率. 需要进行政策调整,以改善结果并确保移植公平.
科学领域:
- 移植医学 移植医学
- 器官分配政策 器官分配政策
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 2018年美国成人心脏分配政策 (aHAP) 的修订增加了同时心脏移植 (SHKT).
- 对aHAP的批评包括它未能改善SHKT接受者的移植后存活率或减少等待名单死亡率.
- 根据目前的政策,高质量的脏在SHKT中被使用.
研究的目的:
- 评估2018年aHAP修订对SHKT结果的影响.
- 为了比较移植后的存活率和移植失败率在政策变化之前和之后.
- 根据修订后的政策,评估SHKT后对脏的不良结果.
主要方法:
- 从器官采购和移植网络 (2015-2021) 中分析了1549个SHKT病例.
- 移植后1年结果的评估,包括移植失败和脏不良事件.
- 倾向性得分匹配用于比较政策实施前 (2018年10月之前) 和后 (2018年10月之后) 的队列.
主要成果:
- 在aHAP实施后的时期,心脏 (HR 1.59) 和脏 (HR 1.39) 的死亡率显著增加 (HR 1.62) 和所有原因的移植失败.
- 在新的aHAP下,脏不良结果的一年发生率为6.8%,而之前在幸存者中为5.3% (P=0.33).
结论:
- 修订后的aHAP导致了SHKT受益人未达到最佳结果.
- 对单独脏移植候选人的潜在负面影响需要考虑.
- 定期监测和潜在的SHKT政策修订对于实现公平性和公用事业目标至关重要.
相关概念视频
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Errors occurring during blood pressure monitoring
580
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
580
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360
Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54


